SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility and heavy selling pressure as investors rotate out of high-flying semiconductor and memory stocks amidst a broader market trend of profit-taking. While some community members are highlighting strong fundamental demand and potential long-term AI-driven growth, others remain cautious, warning of excessive valuations and comparing the recent price action to past speculative bubbles.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility and investor attention as it undergoes index inclusion in the Russell 3000, fueling intense community debate over a potential short squeeze. Investors are divided between those betting on a fundamental turnaround driven by new AI product integrations and those skeptical of its valuation and high short interest.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is currently experiencing high volatility following earnings and the acquisition of Alkira, driving intense community debate over whether the company is an undervalued AI infrastructure play or a struggling legacy firm. Investors are actively discussing the firm's strategic pivot toward high-margin AI connectivity, with bulls emphasizing the firm's massive fiber network and contract backlog while bears remain skeptical of the long-term timeline for revenue growth.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility as part of a broad semiconductor sector rotation, with investors debating whether the sharp pullback is a healthy correction in a long-term AI-driven cycle or the start of a deeper trend reversal. Community sentiment remains deeply divided, characterized by 'buy-the-dip' enthusiasm among those holding long-term conviction and intense frustration from traders navigating rapid price swings and margin pressure.

Roundhill ETF Trust - Roundhill Memory ETF

The DRAM ETF is experiencing heightened volatility driven by global semiconductor investment news and ongoing concerns over antitrust litigation targeting major memory manufacturers. Community sentiment remains polarized, with many investors viewing the current dip as a strategic entry point for a long-term AI-driven supercycle, while others express frustration over the impact of foreign market fluctuations and regulatory headlines.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense selling pressure as investors grapple with skepticism over the company's massive capital expenditure for AI infrastructure and debt-heavy growth strategy. The community is deeply divided, with many traders frustrated by the persistent, relentless downward trend, while others view the current depressed valuation as a bargain-buying opportunity for long-term AI exposure.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing significant selling pressure driven by a combination of retail frustration over executive compensation packages and sector-wide sentiment shifts triggered by headlines regarding hyperscalers monetizing excess compute capacity. While some investors are concerned about dilution and a lack of immediate deal flow, bullish market participants continue to highlight the company's long-term power and data center infrastructure as key assets for the ongoing AI buildout.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing heightened volatility as traders grapple with the semiconductor sector's rapid swings, fueled by conflicting narratives on AI-driven capacity and institutional rebalancing. The community is actively debating the sustainability of the AI trade, with many scalping both sides of the volatility while watching for potential pullbacks amid end-of-quarter adjustments.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense volatility and a significant intraday sell-off despite reporting strong delivery numbers that exceeded analyst expectations. The community is sharply divided, with some investors viewing the price drop as a "sell the news" trap or algorithmic manipulation, while others are aggressively buying the dip or betting on an imminent rebound.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently trending as investors focus on its critical role in the semiconductor supply chain, with community sentiment split between enthusiasm for its AI-driven capacity expansion and concerns over potential volatility amid broader sector rotation. Traders are actively debating the stock's valuation and the impact of analyst price target revisions, while closely monitoring how the equipment sector navigates ongoing margin pressures and high capital expenditure cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Regeneron (REGN) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?

ABBV surged nearly 11% in a week as acquisitions, new approvals and pipeline expansion strengthen confidence in its long-term growth strategy.

Is Regeneron Pharmaceuticals, Inc. (REGN) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?

Is Regeneron Pharmaceuticals, Inc. (REGN) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds...

Here's Why You Should Add Kiniksa Stock to Your Portfolio Now

KNSA's Arcalyst sales continue to grow as raised 2026 revenue guidance and an expanding IL-1 pipeline reinforce Kiniksa's growth strategy.

BAYRY Stock Surges 17% After Supreme Court Roundup Ruling

Bayer shares jump 17% after a Supreme Court ruling on Roundup litigation that could significantly reduce warning-based claims and litigation costs.

Regeneron's Applications for gMG Drug Accepted by FDA and EMA 

Regeneron's cemdisiran won FDA Priority Review and EMA filing acceptance for gMG, backed by phase III data and a potentially unique dosing schedule.

ABBV Jumps on Deepening Immunology Portfolio With $10.9B APGE Buyout

AbbVie shares jump after its $10.9B Apogee deal adds late-stage eczema and respiratory candidates, deepening its immunology pipeline.

Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?

SNY's Dupixent is expanding into new diseases and geographies, strengthening its position as a key driver of long-term revenue growth.

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years

IMRX Begins Dosing in Phase III Pancreatic Cancer Study, Stock Up

Immuneering stock rises after dosing the first patient in a pivotal phase III study of atebimetinib plus mGnP for first-line metastatic pancreatic cancer.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Nasdaq, S&P 500 Futures Retreat After Record Week: Why NVDA, NOW, POET, IBRX, UNH, REGN Are In Focus

Equity

Neutral Sentiment

Track REGN stock price, charts, news and real-time market activity on Stocktwits. Join the REGN message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Regeneron Pharmaceuticals, Inc stock.

REGN Stock Price Today - Regeneron Pharmaceuticals Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$645.29
Prev Close	$624.72
Open	$630.36
Dividend Yield	0.46%
50-Day Moving Average	$659.41
Beta	0.62
Avg. Volume	1.09M
PE Ratio	15.22

52-Week High	$821.11
52-Week Low	$532.60
Market Capitalization	$65.5B
EPS (Annual)	$41.48
Price to Book	2.09
Revenue Per Employee	$930,752.76

Feed

News

Sentiment

Earnings

Fundamentals

Info

REGNRegeneron Pharmaceuticals, Inc.

Latest REGN News